Thank you very much, Madam Chair.
Thank you to all the presenters. I think I have the same 10 minutes as Robert had.
Let's look at it in this fashion: there are reporting elements on a national basis, and not one but many ways that people can report adverse reactions. There are also international avenues where people report adverse reactions; and there are people, as well as stakeholders, reporting directly to the pharmaceutical companies.
Is all of this information being compiled anywhere, in one unit, or is it reported back in as many facets as it is reported inward?